Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322621589> ?p ?o ?g. }
- W4322621589 endingPage "91" @default.
- W4322621589 startingPage "79" @default.
- W4322621589 abstract "•Patients undergoing elective endovascular abdominal aortic aneurysm repair (EVAR) are at risk of contrast-associated acute kidney injury (CA-AKI). •Patients with decreased renal function (glomerular filtration rate < 30 mL/min) are at higher risk of CA-AKI after EVAR. •Patients with a maximum abdominal aortic aneurysm diameter more than 6.9 cm are at higher risk of CA-AKI after EVAR. •Female patients regardless of maximum abdominal aortic aneurysm diameter are at higher risk of CA-AKI after EVAR. Background Contrast-associated acute kidney injury (CA-AKI) after endovascular abdominal aortic aneurysm repair (EVAR) is associated with mortality and morbidity. Risk stratification remains a vital component of preoperative evaluation. We sought to generate and validate a preprocedure CA-AKI risk stratification tool for elective EVAR patients. Methods We queried the Blue Cross Blue Shield of Michigan Cardiovascular Consortium database for elective EVAR patients and excluded those on dialysis, with a history of renal transplant, death during procedure, and without creatinine measures. Association with CA-AKI (rise in creatinine > 0.5 mg/dL) was tested using mixed-effects logistic regression. Variables associated with CA-AKI were used to generate a predictive model via a single classification tree. The variables selected by the classification tree were then validated by fitting a mixed-effects logistic regression model into the Vascular Quality Initiative dataset. Results Our derivation cohort included 7,043 patients, 3.5% of whom developed CA-AKI. After multivariate analysis, age (odds ratio [OR] 1.021, 95% confidence interval [CI] 1.004–1.040), female sex (OR 1.393, CI 1.012–1.916), glomerular filtration rate (GFR) < 30 mL/min (OR 5.068, CI 3.255–7.891), current smoking (OR 1.942, CI 1.067–3.535), chronic obstructive pulmonary disease (OR 1.402, CI 1.066–1.843), maximum abdominal aortic aneurysm (AAA) diameter (OR 1.018, CI 1.006–1.029), and presence of iliac artery aneurysm (OR 1.352, CI 1.007–1.816) were associated with increased odds of CA-AKI. Our risk prediction calculator demonstrated that patients with a GFR < 30 mL/min, females, and patients with a maximum AAA diameter of > 6.9 cm are at a higher risk of CA-AKI after EVAR. Using the Vascular Quality Initiative dataset (N = 62,986), we found that GFR < 30 mL/min (OR 4.668, CI 4.007–5.85), female sex (OR 1.352, CI 1.213–1.507), and maximum AAA diameter > 6.9 cm (OR 1.824, CI 1.212–1.506) were associated with an increased risk of CA-AKI after EVAR. Conclusions Herein, we present a simple and novel risk assessment tool that can be used preoperatively to identify patients at risk of CA-AKI after EVAR. Patients with a GFR < 30 mL/min, maximum AAA diameter > 6.9 cm, and females who are undergoing EVAR may be at risk for CA-AKI after EVAR. Prospective studies are needed to determine the efficacy of our model. Contrast-associated acute kidney injury (CA-AKI) after endovascular abdominal aortic aneurysm repair (EVAR) is associated with mortality and morbidity. Risk stratification remains a vital component of preoperative evaluation. We sought to generate and validate a preprocedure CA-AKI risk stratification tool for elective EVAR patients. We queried the Blue Cross Blue Shield of Michigan Cardiovascular Consortium database for elective EVAR patients and excluded those on dialysis, with a history of renal transplant, death during procedure, and without creatinine measures. Association with CA-AKI (rise in creatinine > 0.5 mg/dL) was tested using mixed-effects logistic regression. Variables associated with CA-AKI were used to generate a predictive model via a single classification tree. The variables selected by the classification tree were then validated by fitting a mixed-effects logistic regression model into the Vascular Quality Initiative dataset. Our derivation cohort included 7,043 patients, 3.5% of whom developed CA-AKI. After multivariate analysis, age (odds ratio [OR] 1.021, 95% confidence interval [CI] 1.004–1.040), female sex (OR 1.393, CI 1.012–1.916), glomerular filtration rate (GFR) < 30 mL/min (OR 5.068, CI 3.255–7.891), current smoking (OR 1.942, CI 1.067–3.535), chronic obstructive pulmonary disease (OR 1.402, CI 1.066–1.843), maximum abdominal aortic aneurysm (AAA) diameter (OR 1.018, CI 1.006–1.029), and presence of iliac artery aneurysm (OR 1.352, CI 1.007–1.816) were associated with increased odds of CA-AKI. Our risk prediction calculator demonstrated that patients with a GFR < 30 mL/min, females, and patients with a maximum AAA diameter of > 6.9 cm are at a higher risk of CA-AKI after EVAR. Using the Vascular Quality Initiative dataset (N = 62,986), we found that GFR < 30 mL/min (OR 4.668, CI 4.007–5.85), female sex (OR 1.352, CI 1.213–1.507), and maximum AAA diameter > 6.9 cm (OR 1.824, CI 1.212–1.506) were associated with an increased risk of CA-AKI after EVAR. Herein, we present a simple and novel risk assessment tool that can be used preoperatively to identify patients at risk of CA-AKI after EVAR. Patients with a GFR < 30 mL/min, maximum AAA diameter > 6.9 cm, and females who are undergoing EVAR may be at risk for CA-AKI after EVAR. Prospective studies are needed to determine the efficacy of our model." @default.
- W4322621589 created "2023-03-01" @default.
- W4322621589 creator A5008077310 @default.
- W4322621589 creator A5058156604 @default.
- W4322621589 creator A5058935102 @default.
- W4322621589 creator A5081236771 @default.
- W4322621589 creator A5086740761 @default.
- W4322621589 date "2023-07-01" @default.
- W4322621589 modified "2023-09-26" @default.
- W4322621589 title "A Novel Preoperative Risk Assessment Tool to Identify Patients at Risk of Contrast-Associated Acute Kidney Injury After Endovascular Abdominal Aortic Aneurysm Repair" @default.
- W4322621589 cites W1952549505 @default.
- W4322621589 cites W1967099627 @default.
- W4322621589 cites W1971485838 @default.
- W4322621589 cites W1977053349 @default.
- W4322621589 cites W1977581480 @default.
- W4322621589 cites W1982848865 @default.
- W4322621589 cites W1984435161 @default.
- W4322621589 cites W1989644699 @default.
- W4322621589 cites W1994837852 @default.
- W4322621589 cites W2000099222 @default.
- W4322621589 cites W2003500862 @default.
- W4322621589 cites W2013058597 @default.
- W4322621589 cites W2017459492 @default.
- W4322621589 cites W2024297271 @default.
- W4322621589 cites W2026274122 @default.
- W4322621589 cites W2042074736 @default.
- W4322621589 cites W2047013647 @default.
- W4322621589 cites W2061514693 @default.
- W4322621589 cites W2064492503 @default.
- W4322621589 cites W2079133009 @default.
- W4322621589 cites W2079433011 @default.
- W4322621589 cites W2093023960 @default.
- W4322621589 cites W2093629089 @default.
- W4322621589 cites W2093916182 @default.
- W4322621589 cites W2104734159 @default.
- W4322621589 cites W2106315724 @default.
- W4322621589 cites W2107807554 @default.
- W4322621589 cites W2113507733 @default.
- W4322621589 cites W2132107848 @default.
- W4322621589 cites W2139863969 @default.
- W4322621589 cites W2145622854 @default.
- W4322621589 cites W2148903912 @default.
- W4322621589 cites W2153104532 @default.
- W4322621589 cites W2154975622 @default.
- W4322621589 cites W2254507851 @default.
- W4322621589 cites W2318036741 @default.
- W4322621589 cites W2348429406 @default.
- W4322621589 cites W2504428358 @default.
- W4322621589 cites W2511214695 @default.
- W4322621589 cites W2522702623 @default.
- W4322621589 cites W2563006826 @default.
- W4322621589 cites W2563231159 @default.
- W4322621589 cites W2765351773 @default.
- W4322621589 cites W2778892312 @default.
- W4322621589 cites W2781996511 @default.
- W4322621589 cites W2980472862 @default.
- W4322621589 cites W2996086431 @default.
- W4322621589 cites W3025005589 @default.
- W4322621589 cites W3099654875 @default.
- W4322621589 cites W3139176206 @default.
- W4322621589 doi "https://doi.org/10.1016/j.avsg.2023.02.017" @default.
- W4322621589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36863491" @default.
- W4322621589 hasPublicationYear "2023" @default.
- W4322621589 type Work @default.
- W4322621589 citedByCount "0" @default.
- W4322621589 crossrefType "journal-article" @default.
- W4322621589 hasAuthorship W4322621589A5008077310 @default.
- W4322621589 hasAuthorship W4322621589A5058156604 @default.
- W4322621589 hasAuthorship W4322621589A5058935102 @default.
- W4322621589 hasAuthorship W4322621589A5081236771 @default.
- W4322621589 hasAuthorship W4322621589A5086740761 @default.
- W4322621589 hasConcept C126322002 @default.
- W4322621589 hasConcept C141071460 @default.
- W4322621589 hasConcept C156957248 @default.
- W4322621589 hasConcept C159641895 @default.
- W4322621589 hasConcept C2776098176 @default.
- W4322621589 hasConcept C2776543907 @default.
- W4322621589 hasConcept C2777323849 @default.
- W4322621589 hasConcept C2778653478 @default.
- W4322621589 hasConcept C2779993416 @default.
- W4322621589 hasConcept C2780120127 @default.
- W4322621589 hasConcept C2780306776 @default.
- W4322621589 hasConcept C2780472472 @default.
- W4322621589 hasConcept C71924100 @default.
- W4322621589 hasConceptScore W4322621589C126322002 @default.
- W4322621589 hasConceptScore W4322621589C141071460 @default.
- W4322621589 hasConceptScore W4322621589C156957248 @default.
- W4322621589 hasConceptScore W4322621589C159641895 @default.
- W4322621589 hasConceptScore W4322621589C2776098176 @default.
- W4322621589 hasConceptScore W4322621589C2776543907 @default.
- W4322621589 hasConceptScore W4322621589C2777323849 @default.
- W4322621589 hasConceptScore W4322621589C2778653478 @default.
- W4322621589 hasConceptScore W4322621589C2779993416 @default.
- W4322621589 hasConceptScore W4322621589C2780120127 @default.
- W4322621589 hasConceptScore W4322621589C2780306776 @default.
- W4322621589 hasConceptScore W4322621589C2780472472 @default.
- W4322621589 hasConceptScore W4322621589C71924100 @default.
- W4322621589 hasLocation W43226215891 @default.